Skip to content

DesiCorp

1 viewer · 30d

Total raised

$3.5M

+$3.5M this year

2 filings since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $3.5M
ROUNDS
2
INVESTORS
8
FOUNDED
N/A
HQ
Louisville, KY
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

DesiCorp is a Louisville, Kentucky biotechnology company that applies anhydrobiosis science to make blood products, vaccines and other biologics stable at room temperature. Its patented ultrasonic process loads trehalose into red blood cells so they can be freeze-dried and later rehydrated, removing the cold chain from transfusion medicine. The technology originated in research at the University of Louisville and has been funded through SBIR/STTR awards and state matching funds. The company also supplies rehydration packaging and domestic manufacturing for shelf-stable healthcare products.

What sets it apart

A patented ultrasonic intracellular trehalose delivery process that makes packed red blood cells freeze-dryable and shelf-stable without refrigeration, extending viability from weeks of cold storage to long-term ambient storage for battlefield, disaster and rural use.

Funding history

2 rounds
Equity+1Mar 20, 2026
Form D
+$840K$3.5M total
Equity+1Mar 20, 2026
Form D/A
+$3.5M$3.5M total

Products

1 tracked

Thermally stable freeze-dried packed red blood cells

Blood product / biologics preservation

Human packed red blood cells stabilized by ultrasonic-mediated intracellular delivery of trehalose and then freeze-dried, producing a powder that stores without refrigeration and is rehydrated at the point of care for transfusion.

  • Patented ultrasonic process for intracellular trehalose loading
  • No refrigeration required for storage or transport
  • Extended shelf life versus weeks for conventional cold-stored blood
  • Closed-system rehydration at the point of care

Links

WebsiteLinkedInSEC EDGAR filings